
- Earth Pharmaceuticals Merger, December 31 End
- Busclin Business Closure Announcement
- Kikidoko Product Transfer to Earth Pharma
- Busclin Company Shutdown Update
- Earth Pharmaceuticals Acquires Busclin
【発表】株式会社バスクリン、12月末で事業終了へhttps://t.co/6bVYOB7Dw5
完全親会社のアース製薬株式会社と合併することに伴い、12月31日をもって事業を終了する。「バスクリン」「きき湯」などの製品については「アース製薬が責任を持って引き継ぎ、これからも大切に育てていきます」と伝えた。 pic.twitter.com/DCeg8cAcpK
— ライブドアニュース (@livedoornews) October 2, 2025
- YOU MAY ALSO LIKE TO WATCH THIS TRENDING STORY ON YOUTUBE. Waverly Hills Hospital's Horror Story: The Most Haunted Room 502
In a recent announcement, Kabushiki Kaisha Basukurin (Basklin Co., Ltd.) has revealed that it will be discontinuing its business operations by the end of December. This decision comes as a result of the company’s complete merger with its parent company, Earth Pharmaceutical Co., Ltd. As of December 31st, all operations under the “Basukurin” and “Kikiburo” brands will be transferred to Earth Pharmaceutical, who will continue to nurture and develop these products with care.
The news of Basukurin’s closure has sparked mixed reactions among consumers and industry insiders alike. Many loyal customers of the brand have expressed sadness and nostalgia over the end of an era, as Basukurin has been a household name for its range of cleaning and personal care products for many years. The company’s signature products, such as their popular Basukurin and Kikiburo lines, have been trusted by consumers for their effectiveness and quality.
Despite the sentimental attachment to the brand, the decision to merge with Earth Pharmaceutical was seen as a strategic move to streamline operations and consolidate resources. By joining forces with Earth Pharmaceutical, Basukurin aims to strengthen its position in the market and ensure the continued success of its products. Earth Pharmaceutical, as the parent company, has pledged to uphold the same standards of quality and integrity that Basukurin is known for, assuring customers of a smooth transition and uninterrupted supply of their favorite products.
The news of Basukurin’s closure has also raised questions about the future of the company’s employees. With the cessation of business operations, many employees are facing uncertainty about their jobs and livelihoods. However, both Basukurin and Earth Pharmaceutical have stated their commitment to supporting their employees through this transition period, offering assistance with job placement and other resources to help them navigate this challenging time.
In the wake of this announcement, industry experts have speculated on the implications of Basukurin’s closure for the wider market. Some have raised concerns about the impact on competition and consumer choice, as Basukurin’s exit may create a void in the market for certain product categories. Others see this as an opportunity for other players in the industry to step up and fill the gap left by Basukurin, potentially leading to innovation and growth in the sector.
Overall, the decision to discontinue business operations by Basukurin marks the end of an era for the company, but also signals a new chapter in its history. As the brand transitions to Earth Pharmaceutical, customers can expect the same level of quality and commitment to excellence that they have come to know and trust. While the closure may be bittersweet for some, it represents a strategic move towards a stronger, more sustainable future for Basukurin and its iconic products.

【発表】株式会社バスクリン、12月末で事業終了へhttps://t.co/6bVYOB7Dw5
完全親会社のアース製薬株式会社と合併することに伴い、12月31日をもって事業を終了する。「バスクリン」「きき湯」などの製品については「アース製薬が責任を持って引き継ぎ、これからも大切に育てていきます」と伝えた。 pic.twitter.com/DCeg8cAcpK
— ライブドアニュース (@livedoornews) October 2, 2025
The news of 株式会社バスクリン (Busukurin Co., Ltd.) announcing the closure of its business by the end of December has left many consumers shocked and saddened. This decision comes as a result of the company’s complete merger with its parent company, アース製薬株式会社 (Earth Pharmaceutical Co., Ltd.), leading to the cessation of operations on December 31. The popular products such as “バスクリン” (Busukurin) and “きき湯” (Kikiburo) will now be taken over by Earth Pharmaceutical, who has committed to nurturing these brands with care and responsibility moving forward.
The announcement made by Busukurin Co., Ltd. marks the end of an era for many loyal customers who have relied on their products for years. The decision to close down operations was not made lightly, but rather as a strategic move in alignment with the merger plans with Earth Pharmaceutical. This move will enable a seamless transition for both companies and ensure the continued availability of Busukurin and Kikiburo products in the market.
For consumers who have grown accustomed to using Busukurin’s products, this news may come as a surprise and raise questions about the future availability of their favorite items. However, with Earth Pharmaceutical taking over the responsibility for these brands, customers can rest assured that the quality and availability of these products will be maintained.
The merger between Busukurin Co., Ltd. and Earth Pharmaceutical represents a significant development in the Japanese consumer goods industry. It signals a consolidation of resources and expertise that will benefit both companies in the long run. By combining forces, the companies aim to streamline their operations and enhance their offerings to better serve their customers.
The commitment from Earth Pharmaceutical to uphold the legacy of Busukurin and Kikiburo products demonstrates a dedication to preserving the trust and loyalty of consumers. The assurance that these brands will continue to be cherished and nurtured under the new ownership is a reassuring message to customers who have relied on these products for their daily needs.
As the news of Busukurin Co., Ltd.’s closure spreads, it is essential for consumers to stay informed about the transition process and any changes that may affect the availability of their favorite products. By keeping an eye on updates from Earth Pharmaceutical and following the latest announcements, customers can ensure a smooth transition and continued access to the products they love.
In conclusion, the announcement of Busukurin Co., Ltd.’s closure and the merger with Earth Pharmaceutical marks a significant milestone in the Japanese consumer goods industry. While the news may come as a shock to many, the commitment from Earth Pharmaceutical to uphold the legacy of Busukurin and Kikiburo products ensures that these beloved brands will continue to thrive under new ownership. Customers can look forward to continued access to these products and the same level of quality they have come to expect.
株式会社バスクリン終了, アース製薬合併, バスクリン製品引き継ぎ, きき湯販売継続, アース製薬責任引き継ぎ, バスクリン事業終了, バスクリンブランド継続, アース製薬製品拡充, バスクリン取り扱い終了, バスクリン株式会社統合, きき湯ブランド継続, アース製薬事業引き継ぎ, バスクリン製品販売終了, バスクリン事業統合, アース製薬株式会社合併, バスクリン撤退, バスクリン製品責任引き継ぎ, きき湯新製品, アース製薬事業買収, バスクリン販売終了